期刊
WORLD NEUROSURGERY
卷 104, 期 -, 页码 95-103出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.wneu.2017.05.010
关键词
Adverse prognostic factor; Gross total resection; Hemangiopericytoma; Postoperative radiotherapy
OBJECTIVE: Intracranial hemangiopericytoma is a rare tumor with high recurrence rate. We analyzed adverse factors for recurrence and survival of patients with hemangiopericytoma. METHODS: We retrospectively reviewed clinical data of 120 patients (mean age, 42 years; 60 male patients) with hemangiopericytoma who were surgically treated in our hospital from December 2008 to January 2016. RESULTS: Gross total resection (GTR) rate was 71.7%. Postoperative adjuvant radiotherapy (PRT) was administered to 63 patients. After median follow-upperiod of 46.9 months, 35 (29.1%) recurrences and 17 (14.1%) deaths were observed. Progression-free survival (PFS) at 1, 3, and 5 years was 90.8%, 78.5%, and 68.0%, and corresponding overall survival rate was 99.2%, 93.7%, and 82.4%. Higher preoperative Karnofsky performance scale scores (hazard ratio [HR] [0.896, 95% confidence interval [CI] [0.845-0.950, p< 0.001), convex surface location (HR=2.151, 95% CI [1.042e4.443, p=0.038), and PRT (HR=0.339, 95% CI=0.159e0.724, p[ 0.005) were independent favorable factors for PFS. For overall survival, higher preoperative Karnofsky performance scale scores (HR=0.914, 95% CI=0.854-0.978, P=0.009), GTR (HR=0.291, 95% CI=0.109-0.777, P=0.014), and PRT (HR=0.210, 95% CI [0.060e0.734, p=0.015) were independent favorable factors. In patients undergoing nonGTR, PRT significantly improved PFS (HR=0.252, 95% CI=0.070-0.906, p[0.035). CONCLUSIONS: This study revealed risk factors for PFS and overall survival to predict outcomes and determine treatments. GTR was attempted as frequently as possible, and PRT was recommended for patients with non-GTR or recurrence to improve tumor control.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据